Alvotech Stock Technical Analysis
| ALVO Stock | USD 3.47 -0.07 -1.98% |
As of the 15th of March 2026, Alvotech reports 3.47 per share in the latest quote. Technical drivers report Mean Deviation of 2.49, risk adjusted performance of -0.15, and Standard Deviation of 3.25. Price momentum and volatility relationships form the basis of the analysis. Cross-sectional analysis places indicator values in market context.
Alvotech Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Alvotech, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to AlvotechAlvotech's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 18.83 | Buy | 4 | Odds |
The summary for Alvotech includes current and past analyst recommendations. The summary includes average consensus context. Following analyst revisions on Alvotech over time reveals trends in institutional sentiment. A string of consecutive target increases for Alvotech often correlates with improving business fundamentals and rising earnings momentum.
Quarterly Earnings Growth -0.58 | Earnings Share 0.23 | Revenue Per Share | Quarterly Revenue Growth 0.106 | Return On Assets |
Market capitalization and book value offer complementary views of Alvotech — the first driven by investor sentiment, the second by accounting standards. Alvotech's market capitalization is 1.08 B. Enterprise value stands at 2.32 B. The intrinsic value concept focuses on underlying worth, which can diverge from market price and book value. Valuation work aligns these measures into a single context.
Value and price for Alvotech are related but not identical, and they can diverge across cycles. For Alvotech, key inputs include a profit margin of 12.12%, and revenue of 489.68 M. Trading price represents the transaction level agreed by market participants.
What if' Analysis
Running a what-if backtest on Alvotech gives investors a practical way to test how changes in horizon, position size, or market timing might have affected the result. Used properly, this review helps investors decide whether Alvotech's historical reward profile was stable enough to support the current thesis.
| 12/15/2025 |
| 03/15/2026 |
A 0.00 position in Alvotech initiated on December 15, 2025 and held to today would record 0.00 in cumulative gains. Overall, this is a 0.0% cumulative return in Alvotech in aggregate over 90 days. Alvotech competes with or is related to Tilray, Phibro Animal, Evotec SE, UFP Technologies, Progyny, Select Medical, and Amphastar. The comparison helps frame competitive context. Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide More
Momentum Range Indicators for Alvotech Summary
Upside/downside measures for Alvotech frame directional pressure and range behavior. This view helps summarize momentum conditions without implying direction.
| Information Ratio | -0.18 | |||
| Maximum Drawdown | 16.71 | |||
| Value At Risk | -5.82 | |||
| Potential Upside | 3.98 |
Volatility and Risk Indicators for Alvotech Summary
These indicators track Alvotech's volatility and return range dynamics. The measures summarize variability without implying direction.| Risk Adjusted Performance | -0.15 | |||
| Jensen Alpha | -0.61 | |||
| Total Risk Alpha | -0.46 | |||
| Treynor Ratio | -1.03 |
Valuation-driven investors use mean reversion to time Alvotech's investments: buying when it trades materially below its historical average valuation multiples and selling when it reaches premium territory.
Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | -0.15 | |||
| Market Risk Adjusted Performance | -1.02 | |||
| Mean Deviation | 2.49 | |||
| Coefficient Of Variation | -515.84 | |||
| Standard Deviation | 3.25 | |||
| Variance | 10.56 | |||
| Information Ratio | -0.18 | |||
| Jensen Alpha | -0.61 | |||
| Total Risk Alpha | -0.46 | |||
| Treynor Ratio | -1.03 | |||
| Maximum Drawdown | 16.71 | |||
| Value At Risk | -5.82 | |||
| Potential Upside | 3.98 | |||
| Skewness | 0.4911 | |||
| Kurtosis | 0.9387 |
Alvotech Backtested Returns
Alvotech suggests a slightly elevated risk exposure over the observed timeframe. It exhibits a Sharpe Ratio (Efficiency) of -0.2, indicating negative risk-adjusted returns over the last 3 months. Technical screening detected twenty-three indicators influencing risk dynamics. Please assess metrics such as standard deviation of 3.25, risk-adjusted performance of -0.15, and mean deviation of 2.49 to evaluate statistical risk alignment. The firm retains a Market Volatility (i.e., Beta) of 0.62, which conveys possible diversification benefits within a given portfolio. With a sub-1 beta, Alvotech participates in market rallies at a reduced pace while also limiting downside exposure. At this point, Alvotech has a negative expected return of -0.66%. Please make sure to validate Alvotech's relationship between the Kurtosis and day typical price, to decide if Alvotech's performance from the past will be repeated sooner or later.
Auto-correlation | -0.08 |
Very weak reverse predictability
Alvotech shows very weak reverse predictability when comparing price series from 15th of December 2025 to 29th of January 2026 against from 29th of January 2026 to 15th of March 2026. A strong serial relationship would imply that Alvotech's recent trajectory contains information about its near-term direction. With a serial correlation of -0.08, barely 8.0% of Alvotech's price variation is attributable to patterns in preceding intervals. Given that Alvotech has negative autocorrelation for the selected time horizon, market participants may evaluate potential contrarian price behavior over comparable future intervals.
| Correlation Coefficient | -0.08 | |
| Spearman Rank Test | -0.23 | |
| Residual Average | 0.0 | |
| Price Variance | 0.34 |
Technical analysis for Alvotech evaluates price and volume patterns over time. The view references moving averages, RSI, regressions, and chart pattern signals.
Technical Analysis
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Alvotech volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Technical Analysis Methodology & Indicators
Technical analysis of Alvotech evaluates price structure, momentum, and volatility clustering. Signal reliability can vary across market regimes and liquidity conditions. Alvotech has a market cap of 1.08 B.
For Alvotech, this section uses periodic company reporting and market reference feeds with Macroaxis normalization rules applied to keep cross-asset comparisons consistent. Analyst inputs may be included when coverage is available. Intraday timing differences may exist.
This content is curated and reviewed by:
Ellen Johnson - Member of Macroaxis Editorial BoardAlvotech Technical Indicators
A technical review of Alvotech can improve timing discipline by comparing momentum, reversal risk, and confirmation signals across several time horizons. The stronger process confirms one signal with others instead of reacting to one pattern in isolation.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | -0.15 | |||
| Market Risk Adjusted Performance | -1.02 | |||
| Mean Deviation | 2.49 | |||
| Coefficient Of Variation | -515.84 | |||
| Standard Deviation | 3.25 | |||
| Variance | 10.56 | |||
| Information Ratio | -0.18 | |||
| Jensen Alpha | -0.61 | |||
| Total Risk Alpha | -0.46 | |||
| Treynor Ratio | -1.03 | |||
| Maximum Drawdown | 16.71 | |||
| Value At Risk | -5.82 | |||
| Potential Upside | 3.98 | |||
| Skewness | 0.4911 | |||
| Kurtosis | 0.9387 |
March 15, 2026 Daily Trend Indicators
A technical review of Alvotech can improve timing discipline by comparing momentum, reversal risk, and confirmation signals across several time horizons. The stronger process confirms one signal with others instead of reacting to one pattern in isolation.
| Accumulation Distribution | 0.05 | ||
| Daily Balance Of Power | -0.39 | ||
| Rate Of Daily Change | 0.98 | ||
| Day Median Price | 3.54 | ||
| Day Typical Price | 3.52 | ||
| Price Action Indicator | -0.10 | ||
| Market Facilitation Index | 0.18 |
More Resources for Alvotech Stock Analysis
A structured review of Alvotech often starts with core financial statements and trend context. Financial ratios provide context for profitability, efficiency, and growth trends. Key reports that frame Alvotech Stock are listed below:Alvotech has a market cap of 1.08 B, operating margin of -2.62%. Trending Equities can help frame allocation decisions. The allocation includes a position in Alvotech in the portfolio view. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in private. Get started with Alvotech Stock investing by reading our How to Invest in Alvotech Stock guide.Analysis related to Alvotech should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Quarterly Earnings Growth -0.58 | Earnings Share 0.23 | Revenue Per Share | Quarterly Revenue Growth 0.106 | Return On Assets |
Market capitalization and book value offer complementary views of Alvotech — the first driven by investor sentiment, the second by accounting standards. Alvotech's market capitalization is 1.08 B. Enterprise value stands at 2.32 B. The intrinsic value concept focuses on underlying worth, which can diverge from market price and book value. Valuation work aligns these measures into a single context.
Value and price for Alvotech are related but not identical, and they can diverge across cycles. For Alvotech, key inputs include a profit margin of 12.12%, and revenue of 489.68 M. Trading price represents the transaction level agreed by market participants.